ALHC

Date of adoption of Rule 10b5-1 plan: 3/13/26

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.29 to $21.14. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Options vested 25% on each of the first four anniversaries of the grant date (03/08/2022), subject to the reporting person's continued service to the Company as of the applicable vesting date.

Date of adoption of Rule 10b5-1 plan: 3/13/26

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.55 to $20.84. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.55 to $20.54. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Date of adoption of Rule 10b5-1 plan: 03/04/2026

Represents 87,719 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of March 13, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Date of Rule 10b5-1 plan adoption: 03/04/2026

Date of adoption of Rule 10b5-1 plan: 03/04/2026

Date of Rule 10b5-1 plan adoption: 05/22/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.19 to $19.80. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Date of Rule 10b5-1 plan adoption: 03/13/2026

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.57 to $20.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Date of Rule 10b5-1 plan adoption: 03/04/2026

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.12 to $20.89. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Balances in column 5 reflect the transfer of 176,125 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.12 to $20.11. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Balances in column 5 reflect the transfer of 176,125 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Represents 122,807 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of March 13, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Represents 87,719 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of March 13, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Represents a bona fide gift to a charitable donor advised fund.

Date of Rule 10b5-1 plan adoption: 05/22/25

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.70 to $16.66. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents a bona fide gift to a family member.

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.22 to $17.70. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.22 to $17.16. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Date of Rule 10b5-1 plan adoption: 05/22/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.76 to $21.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.26 to $21.00. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.31 to $21.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.31 to $21.49. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.18 to $21.17. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.18 to $21.56. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

Date of adoption of Rule 10b5-1 plan: 09/08/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.57 to $17.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Date of Rule 10b5-1 plan adoption: 11/21/25

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.07 to $17.81. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Date of Rule 10b5-1 plan adoption: 11/21/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.18 to $18.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Date of Rule 10b5-1 plan adoption: 05/22/2025

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.12 to $17.60. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

Represents 14,273 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company).

Represents 338,434 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Represents 161,860 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Represents 23,543 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Represents 25,015 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

Represents 51,501 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.